Market Overview:
The global drug-eluting stent market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in drug-eluting stents, and rising demand for minimally invasive procedures. The global drug-eluting stent market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into bare metal stents (BMS), zotarolimus eluting bioresorbable polymer scaffold (ZES-BP), everolimus eluting coronary bioresorbable scaffold (EES), zotarolimus eluting metallic stent (ZES), sirolimus eluting coronary bioresorbable scaffold (SES), paclitaxel eluting coronary bioresorbable scaffold (PES) and others. On the basis of application, the market is segmented into cath labs, hospitals, ambulatory surgical centers(ASCs) and others. Geographically, the global drug-eluted stent market is segmented into North America,, Latin America,, Europe,, Asia Pacific and Middle East & Africa,.
Product Definition:
A drug-eluting stent is a medical device that is inserted into an artery to prop open the vessel and improve blood flow. The stent contains a drug that is released over time to help keep the artery open. Drug-eluting stents are used to treat coronary heart disease, which is caused by atherosclerosis, or plaque build-up inside the arteries.
ZES-BP:
ZES-BP, also known as Zinc Finger Nuclease Biosensor, is a novel diagnostic and monitoring tool for blood vessels. It is an innovative biosensor technology that allows real-time assessment of endothelial damage in the vascular system. The technology has been used to develop Drug Eluting Stents (DES) which are currently under clinical investigation.
EES:
The Electrically Erasable Programmable Read-Only Memory (EEPROM) is a type of memory which can be programmed and read like a regular chip. It is used in various medical devices such as drug eluting stents, implantable pulse generators, insulin pumps etc. The most important application of EES is that it allows the user or physician to customize the device for different patient’s needs by storing their personal data along with medical history in it.
Application Insights:
Based on application, the global demand for drug-eluting stents is segmented into cath labs, hospitals and ASCs. The ASCs held the largest share of over 70.0% in 2017 owing to growing awareness about cardiovascular diseases and rising prevalence of target conditions such as diabetes & hypertension which leads to a higher number of procedures such as heart valve replacement or angioplasty performed there.
The hospital segment is expected to witness lucrative growth during the forecast period due to increasing R&D initiatives by various companies for development of advanced products with better performance characteristics which will eventually boost market penetration.
Regional Analysis:
North America dominated the global drug-eluting stent market in 2016 with a revenue share of over 35%. The growth can be attributed to the presence of key players, high healthcare expenditure, and favorable reimbursement policies. In addition, increasing prevalence of target diseases such as coronary heart disease (CHD) is expected to drive the demand for these products in this region. According to American Heart Association (AHA), around 6.3 million people had Coronary Heart Disease (CHD) in 2015 which was estimated from data provided by CDC and AHA’s Wide-ranging Global Initiative for Cardiovascular Health & Statistics: The Report of the American Heart Association.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Rising geriatric population
- Growing demand for minimally invasive procedures
- Technological advancements in drug-eluting stents (DES)
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug-Eluting Stent Market Research Report
By Type
ZES-BP, EES, ZES, SES, PES
By Application
Cath labs, Hospitals, Ambulatory surgical centers (ASCs)
By Companies
Abbott Laboratories, Biosensors International Group, Boston Scientific, Medtronic, Terumo Corporation, Biotronik, Cook Medical, Envision Scientific, Lepu Medical, Meril Life Sciences, MicroPort Medical, Opto Circuits, Shandong JW Medical Systems, STENTYS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Drug-Eluting Stent Market Report Segments:
The global Drug-Eluting Stent market is segmented on the basis of:
Types
ZES-BP, EES, ZES, SES, PES
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cath labs, Hospitals, Ambulatory surgical centers (ASCs)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Biosensors International Group
- Boston Scientific
- Medtronic
- Terumo Corporation
- Biotronik
- Cook Medical
- Envision Scientific
- Lepu Medical
- Meril Life Sciences
- MicroPort Medical
- Opto Circuits
- Shandong JW Medical Systems
- STENTYS
Highlights of The Drug-Eluting Stent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ZES-BP
- EES
- ZES
- SES
- PES
- By Application:
- Cath labs
- Hospitals
- Ambulatory surgical centers (ASCs)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug-Eluting Stent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A drug-eluting stent is a type of medical device that uses drugs to dissolve and remove the clot from an artery. The device is then removed by a doctor.
Some of the major players in the drug-eluting stent market are Abbott Laboratories, Biosensors International Group, Boston Scientific, Medtronic, Terumo Corporation, Biotronik, Cook Medical, Envision Scientific, Lepu Medical, Meril Life Sciences, MicroPort Medical, Opto Circuits, Shandong JW Medical Systems, STENTYS.
The drug-eluting stent market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug-Eluting Stent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug-Eluting Stent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug-Eluting Stent Market - Supply Chain
4.5. Global Drug-Eluting Stent Market Forecast
4.5.1. Drug-Eluting Stent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug-Eluting Stent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug-Eluting Stent Market Absolute $ Opportunity
5. Global Drug-Eluting Stent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug-Eluting Stent Market Size and Volume Forecast by Type
5.3.1. ZES-BP
5.3.2. EES
5.3.3. ZES
5.3.4. SES
5.3.5. PES
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug-Eluting Stent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug-Eluting Stent Market Size and Volume Forecast by Application
6.3.1. Cath labs
6.3.2. Hospitals
6.3.3. Ambulatory surgical centers (ASCs)
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug-Eluting Stent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug-Eluting Stent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug-Eluting Stent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug-Eluting Stent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug-Eluting Stent Demand Share Forecast, 2019-2029
9. North America Drug-Eluting Stent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug-Eluting Stent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug-Eluting Stent Market Size and Volume Forecast by Application
9.4.1. Cath labs
9.4.2. Hospitals
9.4.3. Ambulatory surgical centers (ASCs)
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug-Eluting Stent Market Size and Volume Forecast by Type
9.7.1. ZES-BP
9.7.2. EES
9.7.3. ZES
9.7.4. SES
9.7.5. PES
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug-Eluting Stent Demand Share Forecast, 2019-2029
10. Latin America Drug-Eluting Stent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug-Eluting Stent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug-Eluting Stent Market Size and Volume Forecast by Application
10.4.1. Cath labs
10.4.2. Hospitals
10.4.3. Ambulatory surgical centers (ASCs)
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug-Eluting Stent Market Size and Volume Forecast by Type
10.7.1. ZES-BP
10.7.2. EES
10.7.3. ZES
10.7.4. SES
10.7.5. PES
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug-Eluting Stent Demand Share Forecast, 2019-2029
11. Europe Drug-Eluting Stent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug-Eluting Stent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug-Eluting Stent Market Size and Volume Forecast by Application
11.4.1. Cath labs
11.4.2. Hospitals
11.4.3. Ambulatory surgical centers (ASCs)
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug-Eluting Stent Market Size and Volume Forecast by Type
11.7.1. ZES-BP
11.7.2. EES
11.7.3. ZES
11.7.4. SES
11.7.5. PES
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug-Eluting Stent Demand Share, 2019-2029
12. Asia Pacific Drug-Eluting Stent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug-Eluting Stent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug-Eluting Stent Market Size and Volume Forecast by Application
12.4.1. Cath labs
12.4.2. Hospitals
12.4.3. Ambulatory surgical centers (ASCs)
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug-Eluting Stent Market Size and Volume Forecast by Type
12.7.1. ZES-BP
12.7.2. EES
12.7.3. ZES
12.7.4. SES
12.7.5. PES
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug-Eluting Stent Demand Share, 2019-2029
13. Middle East & Africa Drug-Eluting Stent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug-Eluting Stent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug-Eluting Stent Market Size and Volume Forecast by Application
13.4.1. Cath labs
13.4.2. Hospitals
13.4.3. Ambulatory surgical centers (ASCs)
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug-Eluting Stent Market Size and Volume Forecast by Type
13.7.1. ZES-BP
13.7.2. EES
13.7.3. ZES
13.7.4. SES
13.7.5. PES
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug-Eluting Stent Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Drug-Eluting Stent Market: Market Share Analysis
14.2. Drug-Eluting Stent Distributors and Customers
14.3. Drug-Eluting Stent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Biosensors International Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Medtronic
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Terumo Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Biotronik
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cook Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Envision Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lepu Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Meril Life Sciences
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. MicroPort Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Opto Circuits
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Shandong JW Medical Systems
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. STENTYS
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
